Intellia Therapeutics, Inc. - NTLA
Sector:
Healthcare
· Industry:
In Vitro & In Vivo Diagnostic Substances
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$2.515B
QoQ value delta ($000)
+$1.017B
(+67.87%)
Implied price effect (QoQ)
+31.99%
Shares
Total shares
148,746,959
QoQ shares delta
+31,790,062
(+27.18%)
Total shares held by funds (by quarter)
Market chart (NTLA)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 334 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.